↓ Skip to main content

AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study

Overview of attention for article published in Frontiers in oncology, February 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
2 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study
Published in
Frontiers in oncology, February 2022
DOI 10.3389/fonc.2022.727505
Pubmed ID
Authors

Zhe Cao, Kristin Delfino, Vivek Tiwari, Xin Wang, Abdul Hannan, Fawwad Zaidi, Andrew McClintock, Kathy Robinson, Yun Zhu, John Gao, Deliang Cao, Krishna Rao

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 13%
Student > Master 2 13%
Student > Bachelor 2 13%
Lecturer 1 6%
Student > Ph. D. Student 1 6%
Other 1 6%
Unknown 7 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 19%
Medicine and Dentistry 2 13%
Business, Management and Accounting 1 6%
Neuroscience 1 6%
Engineering 1 6%
Other 0 0%
Unknown 8 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2023.
All research outputs
#7,694,139
of 26,303,092 outputs
Outputs from Frontiers in oncology
#2,765
of 22,970 outputs
Outputs of similar age
#151,707
of 458,381 outputs
Outputs of similar age from Frontiers in oncology
#186
of 1,570 outputs
Altmetric has tracked 26,303,092 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 22,970 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,381 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 1,570 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.